Loading...
Symbols:
Loading...
Symbols:
AstraZeneca plc (AZN)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on AstraZeneca plc (AZN)
91 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on AZN
- SA Editor Eli Hoffmann(14)
- ChinaBio Today(10)
- Mike Huckman(8)
- Centient Biotech Investor(7)
- Aaron F. Barkoff(6)
Most popular authors
(tracked in watchlists)
- Philip Davis(552)
- Bespoke Investment Group(532)
- SA Editor Eli Hoffmann(379)
- Roger Nusbaum(305)
- Andrew Wilkinson(300)
Most commented on authors
- SA Editor Eli Hoffmann(53)
- Mike Huckman(11)
- Larry Bellehumeur(6)
- Howard Sun (6)
- Bespoke Investment Group(5)
- AstraZeneca Trials Provide Zest and Zeal for OSI Pharmaceuticals
- Fast Money Recap - Will Goldman Be Tarnished? (11/10/08)
- Market Update: Roche/Genentech Deal, AstraZeneca's New Statin, Yahoo, Microsoft Deal?
- AstraZeneca's Cardiovascular Drug: Risks Up, Risks Down
- Wall Street Breakfast: Must-Know News
- Stocks Struggle Around the World
- Ten Healthcare Value Stocks
- FDA Publishes List of Potential Drug Risks
- Bail-out Buys - Fast Money Recap (10/1/08)
- Hard Times Hit Biotech
- Being Short New York - Fast Money Recap (9/22/08)
- Latest FDA Report Highlights: 8 Drugs That Carry Potential Risks
- Yangtze River Delta Developing Huge R&D Base for Drug Companies
- Best Performing ADRs in 2008: VisionChina Heads the List
- Attractively Valued International Dividend Stocks
- AstraZeneca Begins Its Flu Campaign Season, and Pharma Donates to Candidates
- Tough Projections for Big Pharmas: Drug Revenues Don't Look Promising
- AstraZeneca Gives FluMist Spray a Shot in the Arm
- Time to Invest in Pharmaceuticals?
- Abbott Labs Beefs Up Its Drug Portfolio and Stent Business
- How Have 'Traditional Defensive Stocks' Done in This Downturn?
- Wall Street Breakfast: Must-Know News
- Monday Options Outlook: SGP, MRK, AZN, AMGN, CELG, BBH, BAC, KRE, XLF
- Summary Judgment in Seroquel Case Favors AstraZeneca; Teva and Sandoz to Appeal
- AstraZeneca: Size, Safety and Consistency
- Wall Street Breakfast: Must-Know News
- AstraZeneca's Acquisition of MedImmune Still Looks Overpriced
- Will Bayer AG Overtake AstraZeneca in China Drug Sales?
- China Biotech Week in Review: Deals and Drugs
- Mylan Prevails Over AstraZeneca in Appeal of Prilosec Case
- WuXi PharmaTech Signs on for Three More Years with AstraZeneca
- Big Pharma Pipelines Failing to Meet Expectations
- Wall Street Breakfast: Must-Know News
- Esperion Spin-Off: Does It Signal the Start of a New R&D Era?
- Wall Street Breakfast: Must-Know News
- Halfway Through Earnings Season, No Home Runs for Big Pharma
- Starting Monday: Big Pharma Reports This Week
- Wall Street Breakfast: Must-Know News
- Merck and SGP's Vytorin/Zetia: Are Doctors Writing Fewer Scripts?
- 10 Pharmaceutical Stocks and Their Patent Expiration Drugs
- Fast Money Recap, 4/1/08: Gold Takes the Elevator
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »